Computed tomography in metastatic renal cell carcinoma

Area of Science:

• Oncology
• Radiology
• Medical Imaging

Background:

• Metastatic renal cell carcinoma (RCC) management has advanced with new chemotherapy agents.
• These novel therapies offer improved progression-free survival compared to traditional cytokine treatments.
• The increasing efficacy of systemic therapies highlights the growing importance of accurate imaging in patient management.

Purpose of the Study:

• To review the pivotal role of computed tomography (CT) in managing patients with metastatic renal cell carcinoma (RCC).
• To describe the characteristic imaging appearances of metastatic RCC on CT, both before and after systemic therapy.
• To underscore the utility of CT in diagnosis, staging, post-nephrectomy follow-up, and treatment response assessment.

Main Methods:

• Review of current literature on the use of CT in metastatic RCC.
• Description of typical CT findings in metastatic RCC.
• Analysis of CT's role in evaluating treatment efficacy.

Main Results:

• Computed tomography (CT) is the primary imaging modality for metastatic RCC.
• CT is essential for initial diagnosis, staging, and assessing disease extent.
• CT effectively monitors patient response to systemic therapies and disease progression.

Conclusions:

• CT plays an indispensable role throughout the management of metastatic RCC.
• Understanding CT appearances is vital for effective patient care and treatment planning.
• The integration of advanced chemotherapy necessitates a robust role for CT in evaluating treatment outcomes.